Eversight envisions a world without blindness.
Eversight is a leading R&D partner for academia, biotech and pharma, specializing in preventing, treating and curing blinding eye conditions. With 75+ years of eye banking expertise, we offer human eye tissue and biofluids for research, consult on study design and conduct impactful studies in ophthalmology and beyond.
As both an eye bank and a CRO, Eversight combines real-world ophthalmic expertise with CRO capabilities, leveraging state-of-the-art technology and a team of expert scientists. We maximize the use of donor tissue while ensuring quality and good stewardship.
We offer comprehensive services, including research tissue, study design, grant writing, data evaluation, imaging, testing, manuscript preparation, and can facilitate animal model characterization using client-provided tissues.
Operating in Arizona, Connecticut, Illinois, Michigan, New Jersey, Ohio and South Korea, Eversight works with partners worldwide to provide 4,500+ research and 9,600+ transplant tissues annually. Join Eversight in advancing sight restoration and shaping the future of ocular research, driving meaningful progress and creating a legacy that changes lives.